Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Bonder

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
The American Journal of Gastroenterology|June 27, 2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisCumali Efe, Koray Taşçilar, Ida Henriksson, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Journal of Hepatology|July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitisChristophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, et al.
Journal of Hepatology|October 5, 2025
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitisYu Jun Wong, Laurent Lam, Pierre-Antoine Soret, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2024
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary CholangitisLaurent Lam, Pierre-Antoine Soret, Sara Lemoinne, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The American Journal of Gastroenterology|June 27, 2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisCumali Efe, Koray Taşçilar, Ida Henriksson, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Journal of Hepatology|July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitisChristophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?Christophe Corpechot, Sara Lemoinne, Pierre-Antoine Soret, et al.
Journal of Hepatology|October 5, 2025
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitisYu Jun Wong, Laurent Lam, Pierre-Antoine Soret, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2024
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary CholangitisLaurent Lam, Pierre-Antoine Soret, Sara Lemoinne, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Pageof 10